Internal Medicine, Infectious Disease · Henderson, NV
NPI
1053367383
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
10001 S Eastern Ave Ste 307
Henderson, NV, 89052
Phone (702) 909-7170
Groups this clinician bills Medicare through
Medicare paid, 2024
$453K
831,252 services
Medicare patients, 2024
877
Average age 75
Drug cost, 2024
$2.4M
1,986 prescriptions
Company payments, 2025
$3,839
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian J Lipman was code J0878 (injection, daptomycin, 1 mg), 804,000 times for 50 patients. In total Brian J Lipman billed 831,252 services in 48 codes, and Medicare paid $453K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 804,000 | 50 | $0.04 | $34K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 4,296 | 31 | $0.36 | $1,527 |
| 99232 Hospital E&M - Subsequent | Facility | 1,590 | 437 | $56.16 | $89K |
| 96365 Intravenous Infusion, Hydration | Office | 1,142 | 70 | $44.92 | $51K |
| 99214 Office E&M - Established | Office | 961 | 342 | $85.99 | $83K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 953 | 34 | $8.96 | $8,540 |
| 96375 Injection Administration | Office | 672 | 37 | $10.96 | $7,363 |
| 96374 Injection Administration | Office | 479 | 32 | $26.18 | $13K |
| 99223 Hospital E&M - Initial | Facility | 477 | 402 | $122.98 | $59K |
| 99233 Hospital E&M - Subsequent | Facility | 348 | 142 | $84.43 | $29K |
| 99213 Office E&M - Established | Office | 111 | 74 | $62.61 | $6,949 |
| 99204 Office E&M - New | Office | 61 | 61 | $112.01 | $6,833 |
| 99443 Telephone Services | Office | 57 | 29 | $88.04 | $5,018 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 45 | 44 | $147.12 | $6,620 |
| 36592 Vascular | Office | 44 | 15 | $21.81 | $960 |
By year: 2022 $699K for 897,772 services; 2023 $642K for 880,215 services; 2024 $453K for 831,252 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian J Lipman prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 147 prescriptions and refills. In total Brian J Lipman wrote 1,986 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 147 | 147 | 19 | $606K |
| Daptomycin Generic | 135 | 135 | 30 | $285K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 101 | 115 | 12 | $445K |
| Ertapenem Ertapenem Sodium | 92 | 92 | 39 | $38K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 82 | 103 | 25 | $679 |
| Ethambutol Hcl Generic | 81 | 99 | 14 | $3,611 |
| Ciprofloxacin Hcl Generic | 77 | 83 | 45 | $845 |
| Azithromycin Generic | 70 | 93 | 21 | $1,936 |
| Ceftriaxone Ceftriaxone Sodium | 59 | 59 | 19 | $3,870 |
| Meropenem Generic | 53 | 53 | 17 | $9,698 |
| Fluconazole Generic | 52 | 72 | 25 | $3,060 |
| Doxycycline Hyclate Generic | 47 | 78 | 22 | $2,217 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 47 | 47 | Under 11 | $173K |
| Amoxicillin Generic | 44 | 58 | 19 | $1,028 |
| Rifampin Generic | 40 | 48 | 11 | $2,238 |
Brand drugs: - claims; generic drugs: 1,460 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian J Lipman $3,839 ($3,839 in general payments such as food, travel and fees) from 8 companies. The largest payer was La Jolla Pharmaceutical Company with $3,100.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.